Abdool Karim, an infectious diseases epidemiologist and Associate Scientific Director of the Centre for the Aids Programme of Research in South Africa (CAPRISA), focuses her research on the evolution of the human immunodeficiency virus (HIV), such as factors influencing HIV acquisition, interventions to reduce HIV infection in young women; and novel strategies to introduce AIDS treatment in high disease-burden settings. Her landmark 'CAPRISA 004 tenofovir gel' study provided the first evidence of the use of antiretrovirals to prevent the HIV infection, which was published in "Science". Abdool Karim is a Professor in Clinical Epidemiology at the Mailman School of Public Health of Columbia University, in the United States, and in Public Health, at Nelson R. Mandela School of Medicine at the University of KwaZulu-Natal, in South Africa. Her awards include the 2014 TWAS-Lenovo Prize; the Order of Mapungubwe, awarded to South African citizens for achievements with an international impact; the 2016 L'Oreal-Unesco International Award for Women in Science for the Africa and the Arab States region: and the 2021 Special VinFuture Prize for Developing Country Innovators.
Sustainable Development Goals:
3 - Good health and well-being
5 - Gender equality
Section:04-Medical and Health Sciences incl. Neurosciences